Menstrual migraine - Methods of prevention and control

被引:17
作者
Fettes, I
机构
[1] Professor of Medicine, Sunnybrook Health Science Centre, University of Toronto
[2] Division of Endocrinology, Sunnybrook Health Science Centre, Toronto, Ont.
关键词
D O I
10.3810/pgm.1997.05.236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In many women, migraine headaches are clearly linked to estrogen levels: the incidence rises at the menarche; attacks may be precipitated by falling estrogen levels before menses; and symptoms usually improve during pregnancy when there are noncyclic high levels of estrogen. Decreased estrogen production in the perimenopausal phase may trigger an exacerbation of migraine. However, after menopause when estrogen levels are noncyclic and low, there may be an improvement in migraine. The falling estradiol level rather than the absolute level provides the trigger for menstruation-associated migraine. Treatment involves both prophylactic and acute measures. Therapy for an acute attack is similar to that for nonmenstrual migraine. Sumatriptan is equally effective for both nonmenstrual and menstrual migraine.
引用
收藏
页码:67 / &
页数:8
相关论文
共 32 条
[31]  
STEWART WF, 1994, NEUROLOGY S4, V44, pS17
[32]  
SZEKELY B, 1989, CEPHALALGIA S10, V9, P452